Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor alpha (IL-4Ralpha) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis[1].
Molecular Weight:
(147 kDa)
Purity:
99.20
CAS Number:
[1190264-60-8]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted